FRED X – Will surface treatment be a game changer in flow diversion?

From LINNC Paris 2022, Professors Laurent Pierot and Markus A. Möhlenbruch take a deeper look at the innovative FRED X technology and discuss how surface treatment could positively impact on neurovascular strategies in the future.
 
Outlining preliminary data from the FRED X multicentric series, Prof. Möhlenbruch discusses the FRED X technology, a proprietary nanoscale surface treatment developed by Terumo and designed to reduce material thrombogenicity while maintaining natural healing response.

 

INTERVIEW

The CLEVER Study – WEB 17 for Ruptured and Unruptured Aneurysms

INTERVIEW

Microvention Symposium - CLEVER Study & FRED X Multicenter registry

INTERVIEW

X-Technology Surface Treatment: Mechanism of Action

INTERVIEW

What happens when you take one of the best flow diverters in use today and engineer surface modification?

INTERVIEW

A winning team – the novel LVIS EVO stent and HydroCoils!